Ambu (AMBU-B.CO)

Nasdaq Copenhagen · Health care · Financial statements, TTM figures and earnings dates

In fiscal year 2025 (ended September 30, 2025), Ambu reported revenue of DKK 6.04B and net income of DKK 609.0M. Annual financial statements are available for fiscal years 2021 to 2025, taken from the company's ESEF annual reports (IFRS).

Open interactive financials →

Key financials

DKK	FY2025 2025-09-30	FY2024 2024-09-30	FY2023 2023-09-30	FY2022 2022-09-30	FY2021 2021-09-30
Income statement
Revenue	DKK 6.04B	DKK 5.39B	DKK 4.78B	DKK 4.44B	DKK 4.01B
Gross profit	DKK 3.63B	DKK 3.20B	DKK 2.71B	DKK 2.55B	DKK 2.50B
Operating income	DKK 784.0M	DKK 311.0M	DKK 294.0M	−DKK 26.0M	DKK 340.0M
Net income	DKK 609.0M	DKK 235.0M	DKK 168.0M	DKK 93.0M	DKK 247.0M
Diluted EPS	DKK 2.28	DKK 0.88	DKK 0.64	DKK 0.37	DKK 0.98
Cash flow
Operating cash flow	DKK 791.0M	DKK 813.0M	DKK 518.0M	DKK 95.0M	DKK 328.0M
Capital expenditure	DKK 117.0M	DKK 88.0M	DKK 71.0M	DKK 138.0M	DKK 176.0M
Free cash flow	DKK 674.0M	DKK 725.0M	DKK 447.0M	−DKK 43.0M	DKK 152.0M
Balance sheet
Cash and equivalents	DKK 866.0M	DKK 615.0M	DKK 157.0M	DKK 187.0M	DKK 64.0M
Total assets	DKK 7.67B	DKK 7.15B	DKK 6.86B	DKK 7.21B	DKK 5.74B
Total liabilities	DKK 1.64B	DKK 1.56B	DKK 1.47B	DKK 2.95B	DKK 1.79B
Total debt	DKK 5.0M	DKK 0	DKK 0	DKK 1.25B	–
Shareholders' equity	DKK 6.04B	DKK 5.59B	DKK 5.39B	DKK 4.26B	DKK 3.95B

TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in DKK as reported; per-share data adjusted for stock splits.

Annual reports

More on the interactive page

The full AMBU-B.CO page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.

Open AMBU-B.CO financials →